SER-155 is an oral live biotherapeutic being investigated to treat disruptive conditions of the gastrointestinal tract. In a ...

The updated warnings are intended to alert doctors and patients to rare but potentially serious reactions that surfaced after ...

The Central Drugs Standard Control Organisation (CDSCO) has directed all State and Union Territory licensing authorities to ...

Antibiotic resistance is one of the most urgent threats to global health, linked to an estimated 4.7 million deaths worldwide ...

Antibiotic resistance is becoming an accelerating crisis because of the overuse and misuse of antibiotics over many years.

Antibiotic-resistant bacteria can be selectively destroyed by a molecule that uses their our own immunity against them to ...

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company") is a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial ...

WEDNESDAY, April 22, 2026 (HealthDay News) -- The combination of intrawound tobramycin and vancomycin powder is no better than vancomycin powder alone for reducing deep surgical site infection in ...

Orthopedic surgeons commonly use vancomycin and tobramycin powder intraoperatively to reduce infection risk. A randomized trial showed that adding tobramycin was no better than vancomycin alone at ...

Please provide your email address to receive an email when new articles are posted on . A 4-week vancomycin pulse and taper regimen may be a safe and effective strategy to delay or prevent ...

Antibiotics previously thought to help people with cirrhosis manage the risk of hepatic encephalopathy do not appear to benefit the condition. These antibiotics possibly cause more side effects than ...